These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19000676)

  • 21. [Recent topics on nonalcoholic steatohepatitis].
    Saibara T; Onishi S; enzan H
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1104-9. PubMed ID: 12866461
    [No Abstract]   [Full Text] [Related]  

  • 22. Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults.
    Koebnick C; Getahun D; Reynolds K; Coleman KJ; Porter AH; Lawrence JM; Punyanitya M; Quinn VP; Jacobsen SJ
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):597-603. PubMed ID: 19412009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
    Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
    Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Semin Liver Dis; 2008 Nov; 28(4):351-9. PubMed ID: 18956291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty liver in adolescents on the U.S.-Mexico border.
    Sharp DB; Santos LA; Cruz ML
    J Am Acad Nurse Pract; 2009 Apr; 21(4):225-30. PubMed ID: 19366381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of nonalcoholic fatty liver disease: a global perspective.
    Lazo M; Clark JM
    Semin Liver Dis; 2008 Nov; 28(4):339-50. PubMed ID: 18956290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of clinical perspectives and mechanisms of obesity.
    Collins S
    Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):470-1. PubMed ID: 15959883
    [No Abstract]   [Full Text] [Related]  

  • 29. Relation between release of free fatty acid from the adipose tissue and carbon tetrachloride-induced fatty infiltration in the liver.
    Furukawa T
    Wakayama Med Rep; 1965 Mar; 9(4):211-5. PubMed ID: 5824989
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease. A growing problem.
    Mayo Clin Health Lett; 2006 Sep; 24(9):1-3. PubMed ID: 17136797
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease.
    Madan P
    CMAJ; 2005 Sep; 173(7):734-5; author reply 735. PubMed ID: 16186570
    [No Abstract]   [Full Text] [Related]  

  • 33. Obesity and nonalcoholic fatty liver disease.
    Angulo P
    Nutr Rev; 2007 Jun; 65(6 Pt 2):S57-63. PubMed ID: 17605315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty liver: think globally.
    Everhart JE; Bambha KM
    Hepatology; 2010 May; 51(5):1491-3. PubMed ID: 20432252
    [No Abstract]   [Full Text] [Related]  

  • 36. [Strengthen the management of chronic viral hepatitis patients with fatty liver].
    Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):801-3. PubMed ID: 19958634
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy for nonalcoholic fatty liver disease.
    Moseley RH
    J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid metabolism in genetic models of obesity.
    York DA
    Proc Nutr Soc; 1975 Dec; 34(3):249-55. PubMed ID: 174122
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nonalcoholic fatty liver disease and insulin resistance: clinical, biochemical, and morphological parallels].
    Zvenigorodskaia LA; Drozdov VN; Egorova EG
    Eksp Klin Gastroenterol; 2008; (3):25-30. PubMed ID: 19145879
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for progressive liver histology and cardiovascular risk in nonalcoholic fatty liver disease.
    Musso G; Cassader M; Gambino R
    Hepatology; 2012 Aug; 56(2):788-9. PubMed ID: 22371327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.